Today's price action supports the belief that APEVA is valued at next to nothing as of today. Stock looks at least six month ahead. Only if Aixtron can show tangible evidence over the next six month that a system is booked, the situation won't change drastically but slowly improve. The real money is looking at the MOCVD business now, not OLED. There have been noises on weakness of VCSEL and capital spending. Aixtron's price action reflects those noises.
Back to OLED, each deposition system sells fro 100-200m depending on size, number of chambers, configuration etc. See the July 2017 CC (#31652) and:
www.oled-info.com/...ible-oled-deposition-systems-canon-tokki
Cannon Tokki OLED system:
www.canon-tokki.co.jp/eng/product/el/mass.html
Stations 2-9 can be replaced by one OVPD chamber if the customer decides so. Notice that there is still a need for metal cathode deposition (stage 10) so evaporation is still needed albeit a small part. IRUJA might do the chamber for that and the sputtering if it works, but Samsung is known to do its own evaporation source. The Korean JV partner takes care of all the manufacturing chambers and vacuum system and transfer module, etc., while Aixtron delivers just the OVPD source and shower head to Korea for assembly. If Aixtron charges the same price as the incumbent, it could be quite profitable, i.e. high margin. It would take multiple lines for OLED volume production, so potentially there could be several hundred millions of sales annually, but that is a 2020 story. Most investors are not looking at that now, but some would.
There is little doubt that they have to have Samsung's blessing and support for this marriage.